Establishment Labs Holdings (ESTA) Other Non Operating Income (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Other Non Operating Income came in at $479000.0 in Q1 2026, down 82.6% year-on-year from $2.8 million in Q1 2025, and up 161.81% quarter-over-quarter from -$775000.0 in Q4 2025.
Establishment Labs Holdings (ESTA) Other Non Operating Income (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Other Non Operating Income history runs 10 years deep, the most recent figure standing at $479000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 82.6% year-over-year to $479000.0 in Q1 2026; TTM through Mar 2026 was $3.5 million, a 137.32% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 138.06% from the prior year.
- Other Non Operating Income grew to $479000.0 in Q1 2026 per ESTA's latest filing, from -$775000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $4.4 million in Q2 2025 and bottomed at -$19.0 million in Q2 2022.
- The 5-year median for Other Non Operating Income is $479000.0 (2026), against an average of -$1.6 million.
- Across the five-year window, Other Non Operating Income tumbled 1215.48% in 2022 and soared 257.72% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$19.0 million in 2022, then jumped by 115.26% to $2.9 million in 2023, then tumbled by 496.93% to -$11.5 million in 2024, then jumped by 93.27% to -$775000.0 in 2025, then surged by 161.81% to $479000.0 in 2026.
- Per Business Quant, the three latest ESTA Other Non Operating Income figures stand at $479000.0 (Q1 2026), -$775000.0 (Q4 2025), and -$542000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 479,000.00 |
| Dec 31, 2025 | -775,000.00 |
| Sep 30, 2025 | -542,000.00 |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | 2.75 Mn |
| Dec 31, 2024 | -11.52 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Mar 31, 2024 | -3.04 Mn |
| Dec 31, 2023 | 2.90 Mn |
| Sep 30, 2023 | -4.16 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | 729,000.00 |
| Jun 30, 2022 | -19.02 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Jun 30, 2021 | 1.71 Mn |
| Mar 31, 2021 | -2.73 Mn |
| Dec 31, 2020 | 5.56 Mn |
| Sep 30, 2020 | 527,000.00 |